Rates of liver fibrosis assessment and treatment initiation with IFN-free regimens within a screening program for advanced liver fibrosis among HIV/HCV-coinfected patients
D Chromy, M Mandorfer, R Strassl, P Schwabl, S Steiner, B Scheiner, MC Aichelburg, K Grabmeier-Pfistershammer, A Rieger, M Trauner, M Peck-Radosavljevic, T Reiberger · Zeitschrift für Gastroenterologie · 2016 · Heft 05
Bibliografische Angaben
Zusammenfassung
Background: HIV/HCV-coinfected patients (HIV/HCV) have a high risk for liver-related events, especially if they have already developed advanced liver fibrosis (ADVFIB). Aim: To investigate the rates of liver fibrosis assessment and treatment initiation with IFN-free regimens within a screening program for ADVFIB among HIV/HCV. Methods: HIV/HCV treated at the Medical University of Vienna with a FIB-4 index ≥1.45 were counseled by the HIV clinic and referred to the Division of Gastroenterology and Hepatology for liver fibrosis assessment and evaluation for HCV therapy. Results: Among 1348 HIV-positive patients, 31…
